Clinical laboratory testing is generally categorized as either of two general areas–clinical testing and anatomical pathology testing. Clinical and anatomical pathology procedures are frequently ordered as part of regular physician office visits and hospital admissions in connection with the diagnosis and treatment of illnesses. As such, clinical laboratory analysis is one of the most important sections of medical care. The purpose of this TriMark Publications report is to describe the specific segments of the clinical laboratory analysis business. The emphasis in this review is on those companies that are actively developing and marketing laboratory data for the clinical setting, including hospitals, independent labs, physicianâeuro™s offices and miscellaneous clinics. This study concentrates on the clinical laboratory industry in the U.S. It defines the dollar volume of sales in each major market and analyzes the factors that influence the size and the growth of the individual market segments.
The study surveys some of the primary companies known to be marketing clinical laboratory data into the market. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.
Table of Contents :
1. Overview 5
1.1 Objectives of the Report 5
1.2 Methodology 6
1.3 Scope of the Report 7
1.4 Executive Summary 8
2. IVD Clinical Laboratory Market 10
2.1 Introduction 10
2.2 Key Players for Independent Clinical Labs 11
2.3 Medical Expenditures 12
2.4 Medicare Clinical Lab Services Spending Trends 14
3. The Clinical Laboratory Testing Market 17
3.1 U.S. Market 17
3.1.1 Hospital-based Clinical Laboratories 19
3.1.2 Commercial Clinical Laboratory Testing 20
3.1.3 Physician Office Laboratories (POLs) 21
3.2 Clinical Lab Testing Key Players 24
3.2.1 Commercial Clinical Labs 24
3.2.2 Hospital Lab Collaborative Ventures 25
3.2.3 Specialty Labs 26
3.3 Revenue and Reimbursement 27
3.4 Outlook for Clinical Laboratory Testing 30
3.4.1 Long-term Changes 30
3.4.2 Market Drivers 31
3.4.3 Barriers to Successful Clinical Laboratory Operations 32
3.4.4 Key Technologies 35
3.4.5 Conclusion 36
4. Hot Sectors in the Clinical Lab Testing Market 37
4.1 Workplace Drugs-of-Abuse Testing 37
4.2 Clinical Toxicology 38
4.3 Clinical Testing for the Pharmaceutical Industry 38
4.4 Heavy Metal, Trace Element, and Solvent Analyses 38
4.5 Diabetes (Glucose) Testing 39
4.6 Molecular Diagnostic Testing 39
4.7 Cardiac Markers 39
4.8 Blood Bank Screening 39
4.9 Genetic Testing 39
4.10 Predictive Medicine Testing 40
4.11 Personalized Medicine 42
4.12 Cancer Testing 42
4.13 Cell-based Cancer Testing 43
4.14 Monitoring Technologies 43
4.15 Anatomic Pathology 44
5. Important Technology Trends 45
5.1 Technology Platform Innovations in Point-of-Care Testing 45
5.2 The New Paradigm 45
5.3 Consolidated Workstations 45
5.4 Automation in the Laboratory 47
5.5 Laboratory Information Systems 48
5.6 New User-friendly Interface 49
5.7 Data-Management Issues 49
5.7.1 Wireless LANs 50
5.7.2 Data and Workflow Management Systems 50
5.7.3 Beckman Central Command 51
5.7.4 Clinical IT More Widely Available in Physician Practices 51
5.7.5 Physician Electronic Health Records (EHRs) 52
5.7.6 Specimen Tracking and Processing 53
6. Business Trends in the Clinical Laboratory Testing Sector 54
6.1 Key Developments 54
6.2 Sector Consolidation 54
6.3 Acquisition Pricing 54
6.4 A Closer Look at Recent Lab Deals 55
6.5 Acquisition, License Agreements, Internal Development and Partnerships 55
6.6 Merger, Acquisition, Financing and Partnering Activities in the Clinical Lab Industry 56
6.7 Comparison of Quest and LabCorp 58
6.7.1 Acquisitions 58
6.7.2 Questâeuro™s Growth 58
6.7.3 Laboratory Corporation of America 58
6.7.4 LabCorpâeuro™s Growth 59
6.7.5 Competitive Advantages of National Labs like Quest and LabCorp 60
6.7.6 National Managed Care Companies 60
6.7.7 Billing and Collection Management 63
6.7.8 Lower Reagent and Supply Costs 63
6.7.9 Esoteric Testing Capabilities 63
6.7.10 Ability to Invest in Web-based Connectivity Solutions 64
6.7.11 Competitive Disadvantages of Quest and LabCorp 64
6.7.12 Difficulties with Turnaround Times and Stat Services 64
6.7.13 Physician-Laboratory Communication 64
6.7.14 Specimen Pickup Scheduling Inflexibility 64
6.8 Regulation of Clinical Laboratory Operations 65
6.8.1 CLIA and State Regulations 66
6.8.2 Drug Testing 66
6.8.3 Controlled Substances 66
6.8.4 Medical Waste, Hazardous Waste and Radioactive Materials 67
6.8.5 FDA 67
6.8.6 Occupational Safety 67
6.8.7 Specimen Transportation 67
6.8.8 Corporate Practice of Medicine 67
6.9 Hospital Outreach Programs 67
6.10 Supply Chain and GPO Contracting 68
6.11 Specialty Labs 68
6.12 Expansion of Hospital-based Labs and Hospital Outreach Programs 69
6.13 Managed Care 69
For more information please contact :
http://www.aarkstore.com/reports/Clinical-Laboratory-Testing-Volume-2-Business-Strategies-1206.html
http://blogs.aarkstore.com/
From:Aarkstore Enterprise
Contact: Neel
Email: press@aarkstore.com
URL: www.aarkstore.com
Posted in 
